The life sciences community faces many challenges. But after DIA 2024, it’s equally evident that collaborative efforts are yielding solutions. Over the last several days, we’ve had the opportunity to share more about the impact of our digital health technologies in clinical research and the pleasure of connecting with so many people working hard to make a difference. Together, we will continue to enhance healthcare around the world. 💙 #DIA2024 #LifeSciences #DigitalHealthTechnologies #DHT #ActiGraph
ActiGraph’s Post
More Relevant Posts
-
If you missed my presentation at SCOPE, you can catch an adapted version at the 8th Annual DCT conference here in Philly in May!
AGENDA ANNOUNCED for the 8th Decentralized & Hybrid Clinical Trials! On May 15-16, update your clinical recruitment, operations, and partnerships to maintain compliance and build effective #patient networks across remote and hybrid technologies. View the agenda: https://ow.ly/PQm750QFGzG Meet the Speakers: Amy Bohn Brenda Yanak Craig Lipset Dinesh Pillaipakam @Ghassan Ahmed Irina Grishina Joe O'Rourke Katherine Williams Katie Rodammer, M.H.A. Kelsey Kern Len Rosenberg Sandeep Bhat Sarah Doshi Sydney McElroy @Thuy Nguyen Antoniu (Tony) Fantana Victoria L Chiou, MD Wendi Lau, DRSc Zarina Shameer A Special Thanks to: YourBio Health BioMedWire IBN (InvestorBrandNetwork) MEDtube.net PM360 Magazine #DGEvents #decentralizedclinicaltrials
-
-
Circles generate clinical, professional and financial value for our clients. This month's newsletter highlights several current use cases.: https://hubs.li/Q020cvL-0 #realworldevidence #healthcareinnovation #regenmed #RWEcircles
-
Have you seen that this year’s The Effective Statistician Conference includes a very important talk on Estimands and PICOs by Anja Schiel? I will be tuning in tomorrow (14FEB) at 15.00CET and will be looking for insights into how we can make our clinical trials more efficient and suited for both clinical development and health technology assessment purposes. #TES2024 #EUHTA #ESTIMANDSvsPICOs #HTA #PSICOMMUNITY
-
-
BCBN Feed: Trinity Life Sciences Uses New "Tethered" Approach to Integrate HCP-Level Real-World Data and Improve Brand Share Estimates https://lnkd.in/g2ZsEJBG WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting. The method, called “tethering,” uses real-world prescribing behaviors to calibrate share estimates from primary market research (PMR) by connecting them... ... [...]
Trinity Life Sciences Uses New "Tethered" Approach to Integrate HCP-Level Real-World Data and Improve Brand Share Estimates
-
Curious about the iTind™ procedure? Dr. Hollowell provides real-world clinical experience and guidance on patient conversations in this on-demand #webinar. #BPH #iTind #OlympusPost
Real World Experience with iTind™ Procedure
-
Join us at #ISPORAnnual today for a deep dive into key insights in policy, access, value, and evidence. Research posters: - Exploring progression-free survival 2 (PFS2) endpoint trends and uptake in the US healthcare landscape - Utilization of artificial intelligence by health technology assessment agencies to improve efficiency of health technology appraisals - Assessing evidence packages of CRISPR technologies: will they meet payer needs? Join us on Booth 413 to gain insights into navigating competing evidence requirements across US and Global markets. #HEOR #MarketAccess #WeAreAvalereHealth
-
-
Curious about the iTind™ procedure? Dr. Hollowell provides real-world clinical experience and guidance on patient conversations in this on-demand #webinar. #BPH #iTind #OlympusPost
Real World Experience with iTind™ Procedure
-
Curious about the iTind™ procedure? Dr. Hollowell provides real-world clinical experience and guidance on patient conversations in this on-demand #webinar. #BPH #iTind #OlympusPost
Real World Experience with iTind™ Procedure
-
Did you know? In the U.S., roughly 14 billion clinical laboratory tests are performed every year, making them the most utilized medical benefit. In Avalon’s industry’s-only, 3rd annual Lab Trend Report, lab industry experts explore how Avalon is helping health plans use prior authorization and quality differentiation to manage new tests and encourage utilization of only clinically-valid, next-generation sequencing and avoid overuse of unnecessary testing to improve patient outcomes. Access the full report: https://ow.ly/6VKL50PlPlE #AvalonHCS #Healthcare #GeneticTesting #LabTrendReport
Communications, Engagement and Development Executive | Creative Strategist | Client Relationship Expert
3wHate that I missed you but loved dinner with Sam and Michael! Next time.